Plain-English translation of NCT04071015 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing the Biobeat monitor, a wireless device that measures blood pressure and other vital signs without needles or cuffs. Researchers want to see how accurate this new technology is compared to the traditional arterial line method, which involves a thin tube placed in an artery.
Current blood pressure monitoring methods in hospitals can be uncomfortable and invasive. If this wireless device works as well as traditional methods, it could offer patients a more comfortable way to have their vital signs monitored during recovery.
You likely qualify if…
You likely don't qualify if…
After your heart surgery, while you are in the intensive care unit, researchers will attach the Biobeat monitor to your wrist (as a watch) or to your skin (as a patch). You will wear this monitor for 4 hours while your blood pressure and heart activity are recorded every 15 minutes. The monitor works wirelessly and sends information to an app on a phone or tablet, and you will not need any additional needles or procedures beyond the arterial line you already have as part of your care.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Israel
Collaborators
The Chaim Sheba Medical Center
Enrollment target
~250 participants
Started
June 2020
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Arik Eisenkraft, MD, MHA
The Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.